B. Metzler seel. Sohn & Co. Holding AG Acquires New Stake in Henry Schein, Inc. (NASDAQ:HSIC)

B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 7,062 shares of the company's stock, valued at approximately $515,000.

Other hedge funds have also recently modified their holdings of the company. American Century Companies Inc. increased its stake in Henry Schein by 3.1% during the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company's stock worth $351,543,000 after acquiring an additional 162,477 shares during the last quarter. Swedbank AB purchased a new stake in Henry Schein in the 1st quarter valued at about $215,998,000. Nuance Investments LLC lifted its position in Henry Schein by 6.2% in the second quarter. Nuance Investments LLC now owns 1,863,333 shares of the company's stock valued at $119,440,000 after buying an additional 108,143 shares during the last quarter. Burgundy Asset Management Ltd. boosted its stake in Henry Schein by 1.0% during the second quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company's stock worth $105,148,000 after buying an additional 16,476 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in shares of Henry Schein by 10.1% during the second quarter. Dimensional Fund Advisors LP now owns 1,634,384 shares of the company's stock valued at $104,764,000 after acquiring an additional 149,517 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Up 2.3 %

Shares of HSIC stock traded up $1.76 on Monday, reaching $76.84. 2,611,430 shares of the stock were exchanged, compared to its average volume of 1,399,551. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $9.58 billion, a price-to-earnings ratio of 31.62, a PEG ratio of 2.15 and a beta of 0.87. The business's 50 day moving average price is $70.89 and its 200 day moving average price is $69.73.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business's revenue for the quarter was up .4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.32 EPS. As a group, sell-side analysts expect that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. Barrington Research restated an "outperform" rating and issued a $82.00 price objective on shares of Henry Schein in a report on Wednesday, November 6th. JPMorgan Chase & Co. dropped their price objective on Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a research note on Monday, August 12th. StockNews.com raised Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Evercore ISI lifted their target price on Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research report on Tuesday, October 8th. Finally, UBS Group reduced their price target on shares of Henry Schein from $75.00 to $72.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 7th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein presently has an average rating of "Moderate Buy" and a consensus price target of $78.89.

Insider Activity at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. This represents a 22.65 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Michael S. Ettinger sold 12,240 shares of the company's stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares of the company's stock, valued at $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.